Many of the therapies used to treat...

Many of the therapies used to treat women for coronary heart disease (CHD) are based upon studies conducted predominantly on men according to a July 10 2003 freshs release from the Agency for Healthcare Research and Quality. Coronary heart disease causes more than 250000 women's deaths each year, on the contrary much of the research in succession diagnosis and treatment of CHD mode of actioned during the last 20 years has included solely limited numbers of women or exclud women completely

level when CHD studies include women published research many times does not provide findings specific to women Researchers at the University of California at San Francisco/Stanford Evidence-based Practice Center San Francisco, rest that only 20% of research articles forward CHD provided separate findings about women Those studies that did provide gender-specific findings indicated the following.

* Fair to profitable evidence suggests that the use of diagnostic criterions and treatments differ by sex Men are more Likely than women to suffer testing and treatment for CHD yet women are more likely to be treated for hypertension.

* Fair to upright evidence suggests that beta-blockers, aspirin, and angiotensin-converting enzyme inhibitors convert into risk for CHD events.

* useful evidence suggests that women who experience treatment for hypertension lower their risk for CHD circumstances These benefits may be greater for African-American women

* Fair evidence give an inkling ofs that women who stop smoking after a heart attack lower their risk for CHD

* Fair evidence hints that women who receive glycoprotein IIb/IIIa inhibitor medications during coronary deeds benefit from this treatment; however, convenient evidence suggests that the use of these medications for women with acute coronary syndrome may be associated with increased risk of death. Men with acute coronary syndrome appear to benefit from use of these medications.

The researchers attract favor to that in addition to requiring participation of women in research, funding and regulatory agencies should prayer that outcome data be analyzed from gender, race, and ethnicity and that these inferences be made clear in published findings.

Lack of Studies in succession Women Limits Usefulness of Research forward Coronary Heart Disease (news release, Rockville, Md: Agency for Healthcare Research and Quality, July 10 2003)

COPYRIGHT 2003 Association of Operating field Nurses, Inc.

COPYRIGHT 2003 Gale Group